Shareholders of Molecular Partners AG approve all Board proposals at the Annual General Meeting
(WorldNews Switzerland)

Shareholders of Molecular Partners AG approve all Board proposals at the Annual General Meeting Zurich-Schlieren, April 16, 2019. At today`s Annual General Meeting of Molecular Partners AG (SIX: MOLN), a clinical-stage biotech company pioneering the use of DARPin® therapeutics* to treat serious diseases, the shareholders of the company approved all motions proposed by the Board of Directors with a very large majority. At today`s Annual General Meeting of Molecular Partners AG, Bill Burns, Göran Ando, Gwen Fyfe, Steven H. Holtzman, William A. Lee, Petri Vainio and Patrick Amstutz were re-elected as members of the Board of Directors for a term of office until the 2020 Annual General Meeting....